SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014076
Filing Date
2021-11-02
Accepted
2021-11-02 16:02:14
Documents
72
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20210930x10q.htm   iXBRL 10-Q 2571683
2 EX-10.1 rigl-20210930xex10d1.htm EX-10.1 118428
3 EX-31.1 rigl-20210930xex31d1.htm EX-31.1 16166
4 EX-31.2 rigl-20210930xex31d2.htm EX-31.2 16887
5 EX-32.1 rigl-20210930xex32d1.htm EX-32.1 8777
6 GRAPHIC rigl-20210930x10q004.jpg GRAPHIC 138670
  Complete submission text file 0001558370-21-014076.txt   9481056

Data Files

Seq Description Document Type Size
7 EX-101.SCH rigl-20210930.xsd EX-101.SCH 56090
8 EX-101.CAL rigl-20210930_cal.xml EX-101.CAL 51374
9 EX-101.DEF rigl-20210930_def.xml EX-101.DEF 188317
10 EX-101.LAB rigl-20210930_lab.xml EX-101.LAB 495589
11 EX-101.PRE rigl-20210930_pre.xml EX-101.PRE 346134
12 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20210930x10q_htm.xml XML 1739346
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 211371113
SIC: 2834 Pharmaceutical Preparations